<?xml version="1.0" encoding="UTF-8"?>
<p>Both clinical trials and real-life data have demonstrated the high efficacy, favorable safety profile, tolerability, low toxicity, and relatively high genetic barrier to resistance of INSTIs for both na√Øve and ART-experienced patients [
 <xref rid="B7-viruses-12-00838" ref-type="bibr">7</xref>,
 <xref rid="B8-viruses-12-00838" ref-type="bibr">8</xref>,
 <xref rid="B9-viruses-12-00838" ref-type="bibr">9</xref>].
</p>
